scispace - formally typeset
P

Paul Jenö

Researcher at University of Basel

Publications -  76
Citations -  6543

Paul Jenö is an academic researcher from University of Basel. The author has contributed to research in topics: Phosphorylation & Peptide sequence. The author has an hindex of 44, co-authored 75 publications receiving 6143 citations. Previous affiliations of Paul Jenö include University Hospital of Basel.

Papers
More filters
Journal ArticleDOI

Human T Cell Receptor γδ Cells Recognize Endogenous Mevalonate Metabolites in Tumor Cells

TL;DR: In this paper, the authors identify metabolites of the mevalonate pathway as the tumor ligands that activate TCR-γδ cells, and demonstrate that when metabolite accumulation is induced by overexpressing HMGR or by treatment with nitrogen-containing bisphosphonate drugs, tumor cells derived from many tissues acquire the capacity to stimulate the same T cell receptor (TCR-γα)-γα population.
Journal ArticleDOI

PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis.

TL;DR: The identification of Proline-rich Akt substrate (PRAS40) and the hypothetical protein Q6MZQ0/FLJ14213/CAE45978 as new mTOR binding proteins suggest that mTORC2-dissociated PRR5L may promote apoptosis when mTOR is hyperactive.
Journal ArticleDOI

Insulin resistance causes inflammation in adipose tissue

TL;DR: It is reported that obesity-induced insulin resistance in mice precedes macrophage accumulation and inflammation in adipose tissue, and it is suggested that insulin resistant tissue leads to inflammation rather than vice versa.
Journal ArticleDOI

A monoclonal antibody against an activation epitope on mouse integrin chain beta 1 blocks adhesion of lymphocytes to the endothelial integrin alpha 6 beta 1.

TL;DR: The monoclonal antibody 9EG7 can functionally distinguish between different beta 1 integrins and defines a beta 1 Integrin other than alpha 4 beta 1 as a newly discovered cell-cell adhesion molecule.